USPTO serial 85183684
LAVIPHARM
Reviewed by CopyMark Law Group
Reg. 4277949Status 710
- Filing date
- Status date
- Registration date
- Jan 22, 2013
- Examiner
- ALTREE, NICHOLAS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LAVIPHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Peania, Attica, GR
Peania, Attica, GR
Peania, Attica, GR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jay A. Bondell
JAY A. BONDELL Ladas & Parry LLP1040 Avenue of the AmericasNew York, NY 10018-3738UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Tooth whitening preparations; lye washing powder; cleaning, polishing and abrasive preparations; de-greasing preparations for household purposes; soaps; perfumery; essential oils; fingernail embellishments; hairstyling preparations; cosmetics; dentrifices; after-sun emulsions; anti-aging moisturizer; non-medicate skin care preparations, namely, anti-free radical preparations, environmental aggression protectors, and destructive enzyme inhibitors; nonmedicated diaper rash ointments and lotions | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical products, namely, prescription and over-the-counter drugs for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dietary food supplements and health food supplements for children and patients, namely, snacks, gums and resins that are based on natural extracts, soluble vitaminic compounds, minerals, fiber, protein and derivatives, aminoacids, carbohydrates, electrolytes and combinations thereof; dietary food supplements for children and patients for slimming purposes, strengthening nails and/or hair, energy boosting, electrolyte supplementation, or the regulation of physiological functions such as digestion, constipation, heartburn, diarrhea, nausea, colic, and muscle pain; dietetic sugar and fat substitutes for medical use for children and patients; dietetic beverages for medical use for children and patients; dietary fiber as an additive for food products for slimming and lowering cholesterol for children and patients; baby food; powdered milk for babies; dietary food supplements for alleviating diarrhea, colic and constipation for children and patients; dietary food supplements for children and patients; medical plaster; surgical bandages and bandages for skin wounds; dentistry wax; medicated sunscreen and sun block; noncosmetic medicated sun-block lip balms and sticks; antiseptics; medicated bath and douche preparations; bacteriosidal and pH controlling preparations, spermicidal foams, gels, sprays, solutions and impregnated tampons; films and therapeutic dressings for wounds and sores; pharmaceutical preparations for fighting calluses and foot condyloma; pharmaceutical preparations for children and adults for relieving gum pain and aphthae; pharmaceutical preparations for building muscle; medicated skin care preparations, namely, anti-free radical preparations, environmental aggression protectors, and destructive enzyme inhibitors; medicated diaper rash ointments and lotions; veterinary pharmaceuticals, namely, dermatologicals, topical analgesics, vesicant ointments and patches containing antibiotics, hormones, anti-inflammatory agents, ophthalmics, biological fungicides; pharmaceutical preparations for the treatment of stress; pharmaceutical preparations for the treatment of infertility; muscle relaxants; dieting pills and powder preparations to promote fat burning; diuretics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; food additives with therapeutic or prophylactic use, namely, dietary fiber for children or patients; animal feed additives, namely, enzymes for use in animal feeds to assist in digestion; enzymes for medical use; mixes and pre-mixes of vitamin, protein, aminoacid and mineral supplements for children and patients; diagnostic transdermal patches for use in measuring body fluids and contaminants, blood components, hormone levels, drug levels in blood or urine, body irradiation and pollution markers; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of agents for measuring meat parasites and contaminants; antiseptic preparations; medicated and nonmedicated wound dressings; parasiticides and parasite repellants; medical and veterinary diagnostic preparations for disease diagnosis, disease monitoring and measurements on the reproductive cycle; medicated hair conditioners and hair growth promoters; all purpose disinfectants; preparations for killing weeds; insecticidal solutions, gels, sprays, foams, creams, soaps and shampoos; vitamin enriched skin creams; antiseptic solutions and gels; buccal swabs for medical purposes | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 23, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 22, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 22, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 6, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 6, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 17, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 4, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 28, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 28, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2012 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 5, 2012 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Sep 5, 2012 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Aug 14, 2012 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 19, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 19, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 30, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 16, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 8, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 8, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 8, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 9, 2011 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 9, 2011 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 9, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 7, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 7, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 7, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 9, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2011 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 4, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 6, 2010 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 30, 2010 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Nov 29, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 26, 2010 | NWAP | NEW APPLICATION ENTERED | — |